Advanced glycation end-products: a review
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occurring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 20 various AGEs have been detected in blood and tissues, as well as in foods.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The most abundant non-fluorescence AGEs involve carboxymethyl-lysine (CML), and carboxyethyl-lysine (CEL). Fluorescence AGEs involve methylglyoxal-lysine and pentosidine (Singh et al. 2001).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The Maillard reaction generates these highly reactive dicarbonyls, also referred to as 𝛼-oxoaldehydes, which in addition to methylglyoxal include glyoxal and 3deoxyglucosone. [17]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Role of the Maillard Reaction in Aging of Tissue Proteins
Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18714 · Cited by 366
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Non-enzymatic glycosylation and the chronic complications of diabetes: an overview
Kennedy, L., & Baynes, J. W. (1984) · Diabetologia · doi:10.1007/bf00281113 · Cited by 299
Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging
Thorpe, S. R., & Baynes, J. W. (1996) · Drugs & Aging · doi:10.2165/00002512-199609020-00001 · Cited by 285
Negative consequences of glycation
Brownlee, M. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80078-5 · Cited by 284
The role of glycation cross-links in diabetic vascular stiffening
Sims, T. J., Rasmussen, L. M., Oxlund, H., & Bailey, A. J. (1996) · Diabetologia · doi:10.1007/bf00403914 · Cited by 259
Giardino, I., Fard, A. K., Hatchell, D. L., & Brownlee, M. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1114 · Cited by 258
Experimental diabetic neuropathy: an update
Sima, A. A. F., & Sugimoto, K. (1999) · Diabetologia · doi:10.1007/s001250051227 · Cited by 253
Soulis, T., Thallas, V., Youssef, S., Gilbert, R. E., McWilliam, B. G., Cooper, M. E., & Murray-McIntosh, R. P. (1997) · Diabetologia · doi:10.1007/s001250050725 · Cited by 222
Kallenberg, C. G. M., Leontine Mulder, A. H., & Cohen Tervaert, J. W. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90202-m · Cited by 220
Tsuchida, K., Makita, Z., Yamagishi, S., Atsumi, T., Miyoshi, H., Obara, S., Ishida, M., Ishikawa, S., Yasumura, K., & Koike, T. (1999) · Diabetologia · doi:10.1007/s001250051198 · Cited by 215
Biological effects of aminoguanidine: An update
Nilsson, B.-O. (1999) · Inflammation Research · doi:10.1007/s000110050495 · Cited by 212
Booth, A. A., Khalifah, R. G., & Hudson, B. G. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0366 · Cited by 191
He, C., Sabol, J., Mitsuhashi, T., & Vlassara, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1308 · Cited by 191
New biomarkers of Maillard reaction damage to proteins
Wells-Knecht, K. J., Brinkmann, E., Wells-Knecht, M. C., Litchfield, J. E., Ahmed, M. U., Reddy, S., Zyzak, D. V., Thorpe, S. R., & Baynes, J. W. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.41 · Cited by 170
Regulation of cell migration by amphoterin
Fages, C., Nolo, R., Huttunen, H. J., Eskelinen, E.-L., & Rauvala, H. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.4.611 · Cited by 166
The Mechanism of Collagen Cross-Linking in Diabetes: A Puzzle Nearing Resolution
Monnier, V. M., Glomb, M., Elgawish, A., & Sell, D. R. (1996) · Diabetes · doi:10.2337/diab.45.3.s67 · Cited by 164
Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress
Loske, C., Neumann, A., Cunningham, A. M., Nichol, K. A., Schinzel, R., Riederer, P. F., & Münch, G. W. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050108 · Cited by 153
The maillard or browning reaction in diabetes
John, W. G., & Lamb, E. J. (1993) · Eye · doi:10.1038/eye.1993.55 · Cited by 122
Ceriello, A. (1999) · PubMed · Cited by 103
Mechanism of drug-induced lupus
Uetrecht, J. P. (1988) · Chemical Research in Toxicology · doi:10.1021/tx00003a001 · Cited by 93
Cohen, M. P., & Ziyadeh, F. N. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v72183 · Cited by 90
Glycated proteins in diabetes.
Furth, A. J. (1997) · PubMed · Cited by 86
Chromatographic evidence for pyrraline formation during protein glycation in vitro and in vivo
Portero‐Otín, M., Nagaraj, R. H., & Monnier, V. M. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)00209-y · Cited by 86
Takahashi, M., Kushida, K., Ohishi, T., Kawana, K., Hoshino, H., Uchiyama, A., & Inoue, T. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370517 · Cited by 70
Nonenzymatic Glycosylation of Laminin and the Laminin Peptide CIKVAVS Inhibits Neurite Outgrowth
Federoff, H. J., Lawrence, D., & Brownlee, M. (1993) · Diabetes · doi:10.2337/diab.42.4.509 · Cited by 65
Ando, K., Beppu, M., Kikugawa, K., Nagai, R., & Horiuchi, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0606 · Cited by 48
Advanced glycation end-products in diabetic nephropathy
Sugiyama, S., Miyata, T., Horie, K., Iida, Y., Tsuyuki, M., TANAKA, H. L., & Maeda, K. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.91 · Cited by 47
Soulis, T., Sastra, S. A., Thallas, V., Mortensen, S. B., Wilken, M., Clausen, J. T., Bjerrum, O. J., Petersen, H., Lau, J. F., Jerums, G., et al. (1999) · Diabetologia · doi:10.1007/s001250051181 · Cited by 46
Thornalley, P. J., Westwood, M. E., Lo, T. W. C., & McLellan, A. C. (2015) · Contributions to nephrology · doi:10.1159/000424089 · Cited by 37
In Vivo Platelet Activation in Diabetes Mellitus
Strano, A., Davì, G., & Patrono, C. (1991) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002648 · Cited by 36
The contribution of glycation to cataract formation in diabetes.
Stevens, A. (1998) · PubMed · Cited by 35
Quantification of the cross-link pentosidine in serum from normal and uremic subjects
Takahashi, M., KUSHIDA, K., Kawana, K., Ishihara, C., Denda, M., Inoue, T., & Horiuchi, K. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.10.2162 · Cited by 33
The role of glycation cross-links in diabetic vascular stiffening
Sims, T. J., Rasmussen, L. M., Oxlund, H., et al. (1996) · Diabetologia · doi:10.1007/s001250050536 · Cited by 32
Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity
Ceriello, A., Marchi, E., Barbanti, M., Milani, M. R., Giugliano, D., Quatraro, A., & Lefèbvre, P. (1990) · Diabetologia · doi:10.1007/bf00404797 · Cited by 31
Free Radicals Produced during the Oxidation of Hydrazines by Hypochlorous Acid
Goodwin, D. C., Aust, S. D., & Grover, T. A. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960108l · Cited by 30
Implication of carbonyl stress in long-term uraemic complications
Wada, T. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.suppl_1.79 · Cited by 15
Sobal, G., Sinzinger, H. F., & Menzel, E. J. (1999) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899909036650 · Cited by 11
Research works printed but not linked: 2
- Kennedy L (1992) Glycation of immunoglobulins and serum proteins. In: Alberti KGMM, de Fronzo RA, Keen H, Zimmet P (eds) International Textbook of Dia- betes Mellitus, 2nd edn. John Wiley, Chichester pp 985±1007
- Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation end-product induced NF-kappaB acti- vation and cytokine expression. FEBS Letters 453: 283±287
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
“AGEs are related to the aetiology of diabetes and other metabolic alterations.(34,37,38) They have been shown to be elevated in NASH patients compared to simple steatosis and controls, and to be positively correlated with insulin resistance and negatively with adiponectin.”
BackgroundAdvanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
“The combination of increased blood glucose, oxidative and non-oxidative processes result in rearrangements of the Amadori products into the irreversible advanced glycation end products [3,17].”
Background
Metadata
- Authors
- Singh, R., Barden, A., Mori, T., & Beilin, L.
- Affiliations
- The University of Western Australia (AU)
- Venue
- Diabetologia
- Published
- 2001-02-05
- Volume
- 44
- Issue
- 2
- Pages
- 129-146
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1966234811
- Cited by
- 2,597
- References
- 45
- Citations by year
- 2026: 67 · 2025: 85 · 2024: 124 · 2023: 117 · 2022: 152 · 2021: 161 · 2020: 138 · 2019: 142 · 2018: 118 · 2017: 118 · 2016: 130 · 2015: 139 · 2014: 132 · 2013: 114 · 2012: 132
- FWCI
- 36.26
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-30)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- advanced glycation end products, diabetes complications, diabetic microvascular complications, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic vascular disease, carbonyl stress, aminoguanidine
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Food, Humans, Plants, Toxic, Receptors, Immunologic, Nicotiana, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.